| Literature DB >> 27818998 |
Zhihong Xiao1, Dong Ren1, Wei Feng1, Yan Chen1, Wusheng Kan1, Danmou Xing1.
Abstract
The association between height and risk of hip fracture has been investigated in several studies, but the evidence is inconclusive. We therefore conducted this meta-analysis of prospective cohort studies to explore whether an association exists between height and risk of hip fracture. We searched PubMed and EMBASE, Web of Science, and the Cochrane Library for studies of height and risk of hip fracture up to February 16, 2016. The random-effects model was used to combine results from individual studies. Seven prospective cohort studies, with 7,478 incident hip fracture cases and 907,913 participants, were included for analysis. The pooled relative risk (RR) was 1.65 (95% confidence interval (CI): 1.26-2.16) comparing the highest with the lowest category of height. Result from dose-response analysis suggested a linear association between height and hip fracture risk (P-nonlinearity = 0.0378). The present evidence suggests that height is positively associated with increased risk of hip fracture. Further well-designed cohort studies are needed to confirm the present findings in other ethnicities.Entities:
Mesh:
Year: 2016 PMID: 27818998 PMCID: PMC5080474 DOI: 10.1155/2016/2480693
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow diagram of the selection of prospective cohort studies.
Characteristics of epidemiological studies of height and risk of hip fracture included in the meta-analysis.
| Study | Cohort | Age (years) | Number of cases/number of participants | Follow-up years | Endpoint ascertainment | Sex | Exposure level (cm)2 | RR (95% CI) | Adjustment for confounders |
|---|---|---|---|---|---|---|---|---|---|
| Paganini-Hill et al., 1991, US. [ | The Leisure World Study | Median 73 | 418/13,649 | 7 | Medical records | Female | ≧165.1 versus ≦157.5 | 1.26 (0.98, 1.62) | Age |
| Male | ≧180.3 versus ≦170.2 | 1.48 (0.86, 2.55) | |||||||
|
| |||||||||
| Meyer et al., 1993, Norway [ | National Health Screening Service (1974–1990) | 35–49 | 210/52,313 | 10.9 | Medical records | Female | ≧170 versus <155 | 3.62 (1.46, 8.97) | Age |
| Male | ≧185 versus <170 | 2.92 (0.94, 9.05) | |||||||
|
| |||||||||
| Meyer et al., 1995, Norway [ | National Health Screening Service (1963–1975) | 50–89 | 6,087/673,848 | 16.4 | Death certificates | Female | A1: >165 versus ≦157 | 1.26 (0.74, 1.68) | Age |
| A2: >163 versus ≦156 | 1.10 (0.96, 1.26) | ||||||||
| A3: >161 versus ≦154 | 1.19 (1.04, 1.35) | ||||||||
| A4: >160 versus ≦153 | 1.07 (0.81, 1.41) | ||||||||
| Male | A1: >178 versus ≦170 | 0.98 (0.68, 1.42) | |||||||
| A2: >176 versus ≦168 | 1.20 (0.98, 1.45) | ||||||||
| A3: >175 versus ≦167 | 1.10 (0.90, 1.33) | ||||||||
| A4: >174 versus ≦165 | 1.00 (0.67, 1.51) | ||||||||
|
| |||||||||
| Hemenway et al., 1995, US. [ | Nurses Health Study | 35–59 | 243/92,804 | 10 | Self-report, confirmed by medical records | Female | ≧172.7 versus 157.5 | 2.40 (1.43, 4.02) | Age, body mass index, smoking status, alcohol consumption |
|
| |||||||||
| Owusu et al., 1998, US. [ | Health Professionals Follow-Up Study | 40–75 | 56/43,053 | 8 | Self-report | Male | ≧188 versus ≦168 | 3.97 (1.28, 12.3) | Age, weight, calcium intake, smoking, alcohol consumption, waist-to-hip ratio |
|
| |||||||||
| Opotowsky et al., 2003, US. [ | NHANES I Epidemiologic Follow-Up Study | 40–74 | 203/4,264 | 22 | Medical records | Female | B1: ≧168.3 versus ≦155.2 | 3.91 (1.37, 11.13) | Age, weight, age at menopause, hormone use, recreational activity, nonrecreational activity, alcohol use, history of fracture, history of chronic diseases |
| B2: ≧165.4 versus ≦152.0 | 2.01 (1.18, 3.44) | ||||||||
| B3: ≧165.4 versus ≦152.1 | 1.27 (0.70, 2.29) | ||||||||
|
| |||||||||
| Benetou et al., 2011, 5 European countries1 [ | EPIC-Elderly-NAH Study | 60–86 | 261/27,982 | 8 | Self-report or medical records | Female/male | ≧180 versus ≦149 | 1.59 (0.60, 4.22) | Age, educational level, smoking status, history of diabetes mellitus |
1Including Germany, Greece, Italy, Netherlands, and Sweden.
2A1: 50–59 years; A2: 60–69 years; A3: 70–79 years; A4: 80–89 years; B1: 40–59 years; B2: 60–69 years; B3: 70–74 years.
Figure 2A forest plot of the association between height and risk of hip fracture.
Figure 3Dose-response relations between height and relative risk of hip fracture. The solid line and the long dashed lines represent the estimated relative risk and corresponding 95% CI, respectively. There was evidence of a nonlinear association between height and hip fracture risk (P-nonlinearity = 0.0378).
Summary of the results on association between height and risk of hip fracture.
| Variables | Number of studies | RR (95% CI) |
|
|
|---|---|---|---|---|
| Overall | 7 | 1.65 (1.26, 2.16) | 76.2 | 0.000 |
| Location | ||||
| US | 4 | 1.69 (1.27, 2.24) | 50.3 | 0.110 |
| Europe | 3 | 1.72 (0.83, 3.58) | 78.5 | 0.000 |
| Follow-up years | ||||
| <10 | 3 | 1.37 (1.11, 1.69) | 0.0 | 0.543 |
| ≧10 | 4 | 1.88 (1.15, 3.07) | 86.5 | 0.000 |
| Sex | ||||
| Female | 5 | 1.60 (1.18, 2.16) | 78.8 | 0.000 |
| Male | 4 | 1.42 (1.00, 2.02) | 50.9 | 0.106 |
| Both sex | 1 | 1.59 (0.60, 4.22) | NA | NA |
| Number of participants | ||||
| <50000 | 4 | 1.47 (1.22, 1.76) | 0.0 | 0.402 |
| ≧50000 | 3 | 1.96 (0.96, 4.01) | 88.0 | 0.000 |
| Number of cases | ||||
| <400 | 5 | 2.07 (1.62, 2.64) | 0.0 | 0.569 |
| ≧400 | 2 | 1.16 (1.04, 1.29) | 23.6 | 0.252 |
| Study quality | ||||
| Moderate | 2 | 1.69 (0.93, 3.06) | 77.9 | 0.034 |
| High | 5 | 1.71 (1.14, 2.56) | 76.9 | 0.000 |
| Adjustment for confounders | ||||
| Number of confounders | ||||
| <4 | 3 | 1.39 (1.01, 1.91) | 80.0 | 0.007 |
| ≧4 | 4 | 1.94 (1.49, 2.51) | 0.0 | 0.812 |
| Alcohol | ||||
| Yes | 3 | 1.97 (1.50, 2.57) | 0.0 | 0.675 |
| No | 4 | 1.39 (1.04, 1.86) | 71.1 | 0.016 |
| Smoking | ||||
| Yes | 3 | 2.06 (1.43, 2.96) | 0.0 | 0.690 |
| No | 4 | 1.49 (1.11, 2.01) | 80.7 | 0.001 |
| Weight | ||||
| Yes | 2 | 1.83 (1.33, 2.50) | 0.0 | 0.976 |
| No | 5 | 1.58 (1.15, 2.17) | 77.7 | 0.001 |